Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:07:14 UTC 2023
by
admin
on
Sat Dec 16 14:07:14 UTC 2023
|
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
E2UJ1FS3EI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
E2UJ1FS3EI
Created by
admin on Sat Dec 16 14:07:16 UTC 2023 , Edited by admin on Sat Dec 16 14:07:16 UTC 2023
|
PRIMARY | |||
|
P20648
Created by
admin on Sat Dec 16 14:07:16 UTC 2023 , Edited by admin on Sat Dec 16 14:07:16 UTC 2023
|
PRIMARY |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_226 |
| N | 1_494 |
| N | 1_731 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Binds to potassium site
REVERSIBLE
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
reversible and potassium-competitive manner with a potency of inhibition approximately 350 times higher than the proton pump inhibitor, lansoprazole.
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|